vs
Pioneer Bancorp, Inc.(PBFS)与TriSalus Life Sciences, Inc.(TLSI)财务数据对比。点击上方公司名可切换其他公司
Pioneer Bancorp, Inc.的季度营收约是TriSalus Life Sciences, Inc.的1.9倍($25.0M vs $13.2M),Pioneer Bancorp, Inc.净利率更高(82.1% vs -73.9%,领先156.0%),过去两年Pioneer Bancorp, Inc.的营收复合增速更高(144.9% vs 43.0%)
先锋银行控股公司(马里兰州)是一家美国银行控股企业,为先锋银行的母公司,主要面向马里兰州本地社区用户提供零售及商业银行服务,涵盖存款账户、住房与商业抵押贷款、消费贷款及小微企业融资等产品。
TriSalus生命科学公司是一家临床阶段生物技术企业,专注于免疫肿瘤学与介入肿瘤学领域,研发专有的靶向给药技术,用于提升肝脏、胰腺等难治性实体瘤患者的治疗效果,主要在北美市场开展临床合作及业务运营。
PBFS vs TLSI — 直观对比
营收规模更大
PBFS
是对方的1.9倍
$13.2M
净利率更高
PBFS
高出156.0%
-73.9%
两年增速更快
PBFS
近两年复合增速
43.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $25.0M | $13.2M |
| 净利润 | $3.7M | $-9.8M |
| 毛利率 | — | 86.7% |
| 营业利润率 | 21.3% | -24.8% |
| 净利率 | 82.1% | -73.9% |
| 营收同比 | — | 59.8% |
| 净利润同比 | — | 3.5% |
| 每股收益(稀释后) | $0.16 | $-0.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
PBFS
TLSI
| Q4 25 | $25.0M | $13.2M | ||
| Q3 25 | $24.0M | $11.6M | ||
| Q2 25 | $24.4M | $11.2M | ||
| Q1 25 | $22.8M | $9.2M | ||
| Q4 24 | — | $8.3M | ||
| Q3 24 | $22.0M | $7.3M | ||
| Q2 24 | $20.9M | $7.4M | ||
| Q1 24 | $21.6M | $6.5M |
净利润
PBFS
TLSI
| Q4 25 | $3.7M | $-9.8M | ||
| Q3 25 | $4.3M | $-10.8M | ||
| Q2 25 | $6.5M | $-8.3M | ||
| Q1 25 | $5.8M | $-10.4M | ||
| Q4 24 | — | $-10.1M | ||
| Q3 24 | $6.3M | $-2.4M | ||
| Q2 24 | $3.9M | $-4.3M | ||
| Q1 24 | $4.7M | $-13.2M |
毛利率
PBFS
TLSI
| Q4 25 | — | 86.7% | ||
| Q3 25 | — | 83.5% | ||
| Q2 25 | — | 83.9% | ||
| Q1 25 | — | 83.7% | ||
| Q4 24 | — | 85.3% | ||
| Q3 24 | — | 86.3% | ||
| Q2 24 | — | 87.6% | ||
| Q1 24 | — | 85.0% |
营业利润率
PBFS
TLSI
| Q4 25 | 21.3% | -24.8% | ||
| Q3 25 | 23.4% | -77.9% | ||
| Q2 25 | 33.3% | -65.4% | ||
| Q1 25 | 32.5% | -79.9% | ||
| Q4 24 | — | -91.8% | ||
| Q3 24 | 37.2% | -118.9% | ||
| Q2 24 | 24.1% | -111.0% | ||
| Q1 24 | 28.1% | -180.8% |
净利率
PBFS
TLSI
| Q4 25 | 82.1% | -73.9% | ||
| Q3 25 | 18.0% | -93.5% | ||
| Q2 25 | 26.4% | -73.9% | ||
| Q1 25 | 25.3% | -113.2% | ||
| Q4 24 | — | -122.4% | ||
| Q3 24 | 28.7% | -32.6% | ||
| Q2 24 | 107.4% | -58.8% | ||
| Q1 24 | 21.9% | -204.5% |
每股收益(稀释后)
PBFS
TLSI
| Q4 25 | $0.16 | $-0.22 | ||
| Q3 25 | $0.18 | $-0.96 | ||
| Q2 25 | $0.26 | $-0.27 | ||
| Q1 25 | $0.23 | $-0.39 | ||
| Q4 24 | — | $-0.38 | ||
| Q3 24 | $0.25 | $-0.12 | ||
| Q2 24 | $0.15 | $-0.21 | ||
| Q1 24 | $0.19 | $-0.60 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | — | $20.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $323.9M | $-33.9M |
| 总资产 | $2.2B | $35.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
PBFS
TLSI
| Q4 25 | — | $20.4M | ||
| Q3 25 | — | $22.7M | ||
| Q2 25 | — | $26.5M | ||
| Q1 25 | — | $13.0M | ||
| Q4 24 | — | $8.5M | ||
| Q3 24 | — | $11.3M | ||
| Q2 24 | — | $16.5M | ||
| Q1 24 | — | $4.0M |
股东权益
PBFS
TLSI
| Q4 25 | $323.9M | $-33.9M | ||
| Q3 25 | $314.2M | $-26.7M | ||
| Q2 25 | $314.2M | $-19.4M | ||
| Q1 25 | $310.7M | $-34.4M | ||
| Q4 24 | — | $-25.9M | ||
| Q3 24 | $303.8M | $-20.4M | ||
| Q2 24 | $296.5M | $-25.3M | ||
| Q1 24 | $289.0M | $-36.0M |
总资产
PBFS
TLSI
| Q4 25 | $2.2B | $35.3M | ||
| Q3 25 | $2.2B | $36.5M | ||
| Q2 25 | $2.1B | $41.3M | ||
| Q1 25 | $2.1B | $28.6M | ||
| Q4 24 | — | $24.0M | ||
| Q3 24 | $2.0B | $27.5M | ||
| Q2 24 | — | $32.4M | ||
| Q1 24 | $2.0B | $17.9M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $11.1M | $-2.5M |
| 自由现金流经营现金流 - 资本支出 | — | $-2.5M |
| 自由现金流率自由现金流/营收 | — | -19.1% |
| 资本支出强度资本支出/营收 | — | 0.3% |
| 现金转化率经营现金流/净利润 | 2.97× | — |
| 过去12个月自由现金流最近4个季度 | — | $-19.1M |
8季度趋势,按日历期对齐
经营现金流
PBFS
TLSI
| Q4 25 | $11.1M | $-2.5M | ||
| Q3 25 | $3.9M | $-3.7M | ||
| Q2 25 | $5.1M | $-7.3M | ||
| Q1 25 | $-3.5M | $-4.5M | ||
| Q4 24 | — | $-5.7M | ||
| Q3 24 | $1.9M | $-10.8M | ||
| Q2 24 | $9.0M | $-13.4M | ||
| Q1 24 | $3.3M | $-10.9M |
自由现金流
PBFS
TLSI
| Q4 25 | — | $-2.5M | ||
| Q3 25 | — | $-3.9M | ||
| Q2 25 | — | $-7.4M | ||
| Q1 25 | — | $-5.3M | ||
| Q4 24 | — | $-5.8M | ||
| Q3 24 | — | $-11.0M | ||
| Q2 24 | — | $-13.5M | ||
| Q1 24 | — | $-10.9M |
自由现金流率
PBFS
TLSI
| Q4 25 | — | -19.1% | ||
| Q3 25 | — | -33.9% | ||
| Q2 25 | — | -66.1% | ||
| Q1 25 | — | -57.3% | ||
| Q4 24 | — | -69.7% | ||
| Q3 24 | — | -149.9% | ||
| Q2 24 | — | -183.1% | ||
| Q1 24 | — | -169.3% |
资本支出强度
PBFS
TLSI
| Q4 25 | — | 0.3% | ||
| Q3 25 | — | 1.9% | ||
| Q2 25 | — | 0.8% | ||
| Q1 25 | — | 8.2% | ||
| Q4 24 | — | 0.6% | ||
| Q3 24 | — | 2.3% | ||
| Q2 24 | — | 0.8% | ||
| Q1 24 | — | 1.0% |
现金转化率
PBFS
TLSI
| Q4 25 | 2.97× | — | ||
| Q3 25 | 0.90× | — | ||
| Q2 25 | 0.78× | — | ||
| Q1 25 | -0.61× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.30× | — | ||
| Q2 24 | 2.30× | — | ||
| Q1 24 | 0.70× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图